CF10 is much more potent than 5-FU against CRC cells (>300-fold on average in the NCI60 cell line screen)[21], and this increased potency corresponds to stronger TS inhibition by CF10 at correspondingly lower doses relative to 5-FU. This evidence concerns the gene TYMS and colorectal carcinoma.